Febuxostat 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FH6QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,933
Award facts
- Contract value 100% obligated
- $2,933.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,933.10 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count) on October 29, 2025, with completion scheduled for October 30, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive track record of competitively awarded delivery orders through the DLA demonstrates its capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains at varying order values. This specific delivery order for Febuxostat, a medication used in gout management, represents a routine fulfillment under the broader prime vendor contract structure.
Quick answers
Who was awarded contract SPE2DB26FH6QN?
SPE2DB26FH6QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FH6QN worth?
The government has obligated $2,933 on SPE2DB26FH6QN.
Is contract SPE2DB26FH6QN an order under another contract?
Yes. SPE2DB26FH6QN is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB26FH6QN competed?
The extent of competition for SPE2DB26FH6QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award